StonvexLoading…
StonvexStonvexStonvexCore line items from SI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $16.71M | $47.32M | $32.90M | $21.14M |
Operating Income | $-8.98M | $-26.30M | $-17.80M | $-10.16M |
Net Income | $-8.38M | $-40.36M | $-32.59M | $-19.20M |
EPS (Diluted) | $-0.41 | $-4.65 | $-7.00 | $-232.13 |
Total Assets | $160.36M | $169.91M | $177.76M | $77.83M |
Total Liabilities | $27.34M | $29.16M | $29.93M | $29.33M |
Cash & Equivalents | $11.49M | $26.87M | $54.93M | $27.05M |
Free Cash Flow OCF − CapEx | $-15.09M | $-36.02M | $-24.95M | $-13.59M |
Shares Outstanding | 20.70M | 20.62M | 20.58M | 2.84M |